In the immunotherapy using anti-CTLA-4 or IL-2 in mice, the production of tumor necrosis factor-a (TNF-a) in tumor cells and the accumulation of T cells led to an increase in EZH2 expression in melanoma cells. Here, EZH2 is linked to melanoma.